Cargando…
2D and 3D similarity landscape analysis identifies PARP as a novel off-target for the drug Vatalanib
BACKGROUND: Searching for two-dimensional (2D) structural similarities is a useful tool to identify new active compounds in drug-discovery programs. However, as 2D similarity measures neglect important structural and functional features, similarity by 2D might be underestimated. In the present study...
Autores principales: | Gohlke, Bjoern-Oliver, Overkamp, Tim, Richter, Anja, Richter, Antje, Daniel, Peter T., Gillissen, Bernd, Preissner, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4582733/ https://www.ncbi.nlm.nih.gov/pubmed/26403354 http://dx.doi.org/10.1186/s12859-015-0730-x |
Ejemplares similares
-
Endogenous Bak inhibitors Mcl-1 and Bcl-x(L): differential impact on TRAIL resistance in Bax-deficient carcinoma
por: Gillissen, Bernhard, et al.
Publicado: (2010) -
Targeted therapy of the XIAP/proteasome pathway overcomes TRAIL-resistance in carcinoma by switching apoptosis signaling to a Bax/Bak-independent ‘type I' mode
por: Gillissen, B, et al.
Publicado: (2013) -
Data showing the circumvention of oxaliplatin resistance by vatalanib in colon cancer
por: To, Kenneth K.W., et al.
Publicado: (2016) -
Pan-class I PI3-kinase inhibitor BKM120 induces MEK1/2-dependent mitotic catastrophe in non-Hodgkin lymphoma leading to apoptosis or polyploidy determined by Bax/Bak and p53
por: Müller, Anja, et al.
Publicado: (2018) -
The VEGF inhibitor vatalanib regulates AD pathology in 5xFAD mice
por: Jeon, Seong Gak, et al.
Publicado: (2020)